ULTRA CA+ Dermal Matrix 2×0.8ml
30% Calcium Hydroxylapatite (CaHA) Microspheres + 70% CMC Carrier Gel
Particle Size: 25-45 μm (Spherical, porous surface structure)
pH Level: 6.8 – 7.4
Osmolality: 280 – 320 mOsm/kg
Biocompatibility Rate: 98.7%
Adverse Event Incidence: < 0.02%
Degradation Mechanism: Macrophage phagocytosis into Ca2+ and PO43- ions.
Rheological Profile
Elastic Modulus (G’): 1,850 Pa (High lift capacity)
Viscous Modulus (G”): 450 Pa
Tan δ (G”/G’): 0.24 (Firm gel structure)
Extrusion Force: 12-15 N (Smooth injection profile)
Clinical Efficacy Data
*CosmoDerma Clinical Trials, N=124, 12-Week Post-Treatment
Type I Collagen Production: + 68.4%
Type III Collagen Production: + 24.1%
Elastin Fiber Density: + 31.2%
Dermal Thickness Increase: + 2.4 mm (Mean, Ultrasound measured)
Standardized Application Protocol
Instrumentation
• 27G 13mm needle (Deep dermal)
• 22G/25G 50mm cannula (Subdermal/Supraperiosteal)
Dosage Kinetics
• Injection rate: 0.1 ml/sec
• Max volume/session: 2.0 ml per focal area
Post-Procedure
• Active digital molding: 3-5 mins
• Bio-integration timeframe: 8-12 weeks
Regulatory & Safety Compliance
Manufactured in an ISO 13485:2016 and KFDA registered facility (Reg: 2023-AC872). Product intended strictly for use by licensed and board-certified medical practitioners. Do not inject into highly vascularized areas (glabella, nose). Ensure aseptic technique. Storage requirement: 2°C to 25°C, away from direct sunlight. Do not freeze.

Reviews
There are no reviews yet.